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Epigallocatechin gallate (EGCG), a major polyphenol in green tea, possesses antioxidant properties
and regulates various cell functions. Here, we examined the function of EGCG in inﬂammatory bone
resorption. In calvarial organ cultures, lipopolysaccharide (LPS)-induced bone resorption was
clearly suppressed by EGCG. In osteoblasts, EGCG suppressed the LPS-induced expression of COX-2
and mPGES-1 mRNAs, as well as prostaglandin E2 production, and also suppressed RANKL expres-
sion, which is essential for osteoclast differentiation. LPS-induced bone resorption of mandibular
alveolar bones was attenuated by EGCG in vitro, and the loss of mouse alveolar bone mass was
inhibited by the catechin in vivo.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In bone tissues, bone mass is regulated by bone resorption and
bone formation, and bone resorption is elicited by osteoclasts dif-
ferentiated from the macrophage lineage cells. Previous studies
have identiﬁed the receptor activator of NF-jB ligand (RANKL),
also known as the osteoprotegerin (OPG) ligand [1–4], as a pivotal
factor required for osteoclast differentiation. Osteoblasts express
RANKL in response to bone-resorbing factors such as lipopolysac-
charide (LPS) and IL-1, and interact with osteoclast precursors
expressing RANK, inducing their differentiation into matureosteoclasts by a mechanism involving the RANK-RANKL interaction
[3,4].
PGE2 is a typical mediator associated with inﬂammation, and is
produced by various types of cells. In bone tissue, PGE2 is mainly
produced by osteoblasts, and is one of the major inducers of
RANK-dependent osteoclast differentiation and osteoclastic bone
resorption [5]. Previous studies have shown that
cyclo-oxygenases (COX)-2 and membrane-bound PGE synthase
(mPGES)-1 are inducible enzymes that initiate PGE biosynthesis
in various cells, including osteoblasts, after inﬂammatory stimuli
[6,7]. We have reported that the bone resorption associated with
inﬂammation was attenuated in mPGES-1-deﬁcient mice
(mPges1/) due to the lack of PGE production by osteoblasts [7].
Therefore, the PGE2 produced by osteoblasts is a critical regulator
of bone metabolism.
Previous studies have shown that compounds in fruits and veg-
etables are beneﬁcial to our health. Among these, polyphenols,
including ﬂavonoids, are known to exhibit physiological and phar-
macological properties such as anti-oxidative, anti-bacterial and
anti-tumor activities [8,9]. Isoﬂavones have been reported to show
beneﬁcial effects on the bone mass in vivo [10]. Catechins are major
T. Tominari et al. / FEBS Open Bio 5 (2015) 522–527 523ﬂavonoids naturally present in certain species of plants, including
tea. ()-Epigallocatechin-3-gallate (EGCG), a major component of
green tea catechins, has been reported to show the strongest
effects among the catechins on various cell functions, and exhibits
anti-oxidant and anti-tumor activity [8,9]. However, there have
been only a few studies of the effects of EGCG on bone metabolism
and skeletal health. Catechin is reported to enhance alkaline phos-
phatase activity in osteoblasts and osteogenic differentiation of
mesenchymal stem cells [11,12], and EGCG inhibits osteoclastic
differentiation from macrophage [13], but the effects of EGCG on
inﬂammatory bone resorption are not known.
It is known that periodontitis is initiated by a synergistic and
dysbiotic microbial community, and the recent pathological con-
cept for reasoning of periodontal diseases is based on the polymi-
crobial synergy and dysbiosis (PSD) model [14], Periodontal plaque
from the disease site induces inﬂammatory responses through
Toll-like receptor (TLR) activation [15], and the simultaneous infec-
tion with P. gingivalis is also required. Our model for inﬂammatory
bone resorption of alveolar bone is focused and mimicked on the
periodontal bone resorption which is based on the TLR4-induced
osteoclastgenesis in mice [7]. Using our model of the destruction
of alveolar bone in vivo, we have reported that PGE2 is closely
related to the LPS-induced alveolar bone resorption, since we
detected LPS-induced alveolar bone resorption in wild-type mice,
but not in mPGES-1-null mice [7]. Therefore, PGE2 production
may play a key role in LPS-induced alveolar bone resorption via
TLR4 in mice [7].
We examined the inﬂuence of EGCGon the calvarial bone resorp-
tion induced by LPS, and on the COX-2- and mPGES-1-dependent
PGE synthesis in mouse osteoblasts. EGCG inhibited LPS-induced
osteoclastic bone resorption by suppressing the PGE2 production
by osteoblasts in vitro, and attenuated the inﬂammatory bone loss
of the mouse mandibular alveolar bone in vivo.A
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Fig. 1. The chemical structure of EGCG, and the effects of EGCG on the LPS-induced
bone-resorbing activity in organ cultures of mouse calvariae. (A) The chemical
structure of EGCG. (B) Mouse calvariae were cultured for 24 h in BGJb containing
1 mg/ml of BSA. After 24 h, the calvariae were transferred to new media, and were
cultured for ﬁve days with or without 1 lg/ml of LPS and with or without EGCG (30,
60 or 90 lM). The concentration of calcium in the medium was measured to
calculate the bone-resorbing activity. The data are expressed as the means ± SEM of
four to 10 independent wells. A signiﬁcant difference between the two groups was
indicated by: ⁄⁄⁄p < 0.001 vs. control, #p < 0.05, ##p < 0.01, ##p < 0.001 vs. LPS.2. Materials and methods
2.1. Animals and experimental reagents
Mice of ddy strain were obtained from Japan SLC Inc. (Shizuoka,
Japan), and animal experiments were performed under the institu-
tional guidelines for animal research. LPS was obtained from Sigma
Aldrich Co. LLC., MO, USA. EGCG was obtained from Nagara Science
Corporation, Japan (Purity: more than 99%) for in vitro study, and
from Taiyo Kagaku Co. Ltd. (Sunphenon EGCG-OP; Purity: more
than 90%) for in vivo study.
2.2. Culture of primary mouse osteoblastic cells
Primary osteoblastic cells were isolated from newborn mouse
calvariae after ﬁve routine sequential digestions with 0.1% collage-
nase (Roche Applied Science) and 0.2% dispase (Roche Diagnostics
GmbH, Mannheim, Germany), as described previously [7].
Osteoblastic cells collected from fractions two to four were com-
bined and cultured in a-modiﬁed MEM (aMEM) supplemented
with 10% fetal calf serum (FCS) at 37 C under 5% CO2 in air.
After 24 h in culture, they were treated with LPS with and without
EGCG, and further cultured for 24 h for measurement of PGE2.
2.3. Measurement of the PGE2 content
The concentrations of PGE2 in culture samples were calculated
using an enzyme immunoassay (EIA) (GE Healthcare UK Ltd). The
cross-reactivity of the antibody in the EIA was calculated as fol-
lowed: PGE2, 100%; PGE1, 7.0%; 6-keto-PGF1a, 5.4%; PGF2a, 4.3%
and PGD2, 1.0%.2.4. Bone-resorbing activity in organ cultures of mouse calvaria
Calvariae were collected from newborn mice, dissected in half
and cultured for 24 h in BGJb containing 1 mg/ml of bovine serum
albumin (BSA). After 24 h, the calvaria were transferred to new
medium with or without EGCG and with or without LPS, and were
cultured for another ﬁve days. The concentration of calcium in the
conditioned medium was measured by the o-cresolphthalein com-
plexon (OCPC) method. The bone-resorbing activity was expressed
as the increase in the medium calcium concentration.
2.5. Quantitative PCR analysis
Mouse osteoblastic cells were cultured for 3, 6, 12 and 24 h in
aMEM containing 1% FCS with or without LPS and with or without
EGCG, and total RNA and cDNA were prepared as shown in
previous papers [5,7], and the quantitative-PCR (q-PCR) was per-
formed. The primer pairs used in the q-PCR for the mouse
RANKL, COX-1, COX-2, mPGES-1, mPGES-2 and cPGES genes were
as follows: Mouse RANKL: 50-AGGCTGGGCCAAGATCTCTA-30 (for-
ward) and 50-GTCTGTAGGTACGCTTCCCG-30 (reverse), mouse
COX-1: 50-ACTGGTGGATGCCTTCTCTC-30 (forward) and 50-TCTCGG
GACTCCTTGATGAC-30 (reverse), mouse COX-2: 50-GGGAGTCTGGA
ACATTGTGAA-30 (forward) and 50-GTGCACATTGTAAGTAGGTGGAC
T-30 (reverse), mouse mPGES-1: 50-GCACACTGCTGGTCATCAAG-30
(forward) and 50-ACGTTTCAGCGCATCCTC-30 (reverse), mouse
mPGES-2: 50-CGTGAGAAGGACTGAGATCAAA-30 (forward) and 50-
GAGGAGTCATTGAGCTGTTGC-30 (reverse), mouse cPGES: 50-CGAA
TTTTGACCGTTTCTCTG-30 (forward) and 50-TGAATCATCATCTGCTC
CATCT-30 (reverse). The cDNA of the respective genes was
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Fig. 2. The effects of EGCG on the LPS-induced expression of COX-1, COX-2, mPGES-1, mPGES-2, cPGES and RANKL mRNA, and on the production of PGE2 in mouse primary
osteoblasts. (A) Mouse osteoblasts were treated with 1 ng/ml of LPS with or without 30 lM EGCG for 3, 6, 12 or 24 h, and the total RNA was extracted. The mRNA expression
levels of COX-1, COX-2, mPGES-1, mPGES-2, cPGES and RANKL were detected by q-PCR. The relative normalized expression was calculated by the determining the respective
data for control cultures without LPS and EGCG at 3 h. The treatment groups were indicated as: control (s), LPS (j), LPS plus EGCG (4) and EGCG (X). The data are expressed
as the means ± SEM of three independent wells. A signiﬁcant difference between the two groups is indicated as: ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001 vs. control, #p < 0.05,
##p < 0.01, ###p < 0.001 vs. LPS. (B) Mouse osteoblasts were treated with 10 ng/ml of LPS with or without 30 lM EGCG for 24 h, and the levels of PGE2 were measured using the
conditioned media. The data are expressed as the means ± SEM of four independent wells. A signiﬁcant difference between the two groups is indicated as: ⁄⁄⁄p < 0.001 vs.
control, ###p < 0.001 vs. LPS.
524 T. Tominari et al. / FEBS Open Bio 5 (2015) 522–527quantiﬁed by q-PCR with SsoAdvanced SYBR Green Supermix
(Bio-Rad), and the results are shown as the relative expression
compared with the control group (without LPS and EGCG) at 3 h.
2.6. Bone-resorbing activity of mouse mandibular alveolar bone in
organ cultures
Mouse mandibular alveolar bone were collected from the molar
region and three molars were removed under a microscope. The
isolated alveolar bone were cultured for 24 h in BGJb containing
1 mg/ml BSA. After 24 h in the organ cultures, the alveolar bonewas transferred to new media, with or without LPS and with or
without EGCG, and was cultured for another ﬁve days. The
bone-resorbing activity was determined by the increase in medium
calcium compared to control culture [7].
2.7. Inﬂammatory bone loss of the mouse alveolar bone in vivo
In the model of experimental periodontitis, LPS (25 lg/mouse)
was dissolved in 50 lL of PBS and injected into the outside of the
lower gingiva of the mice on days 0, 2 and 4. As a control, PBS
was injected into the lower gingiva at the same time points.
T. Tominari et al. / FEBS Open Bio 5 (2015) 522–527 525After seven days of the ﬁrst injection, the mandibular alveolar
bones were collected from mouse molar region, and three molars
were removed. The bone mineral density (BMD) of the total area
of alveolar bone was measured by DEXA [7].
2.8. Statistical analysis
Data were analyzed using one-way ANOVA, followed by Tukey’s
test for post hoc analysis. All data are presented as the
means ± SEM, and all statistical analyses were performed using
IBM SPSS Statistics Ver.23 software.##
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Fig. 3. The effects of EGCG on LPS-induced bone resorption in organ cultures of
mouse mandibular alveolar bone. (A) Mandibular alveolar bone specimens were
collected from the molar region of the lower jaw under a microscope, and three
molars were removed. (B) The collected mandibular alveolar bones were cultured
for ﬁve days with EGCG (30, 60 or 90 lM) with or without LPS (1 lg/ml). The
concentration of calcium in the mediumwas measured, and the increase in medium
calciumwas calculated as the bone-resorbing activity. The data are expressed as the
means ± SEM of four independent wells. Signiﬁcant differences are indicated by:
⁄⁄p < 0.01 vs. control. ##p < 0.01, vs. LPS.
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Fig. 4. The administration of EGCG inhibited the LPS-induced loss of mandibular
alveolar bone in mice. As a model for experimental periodontitis, LPS (25 lg/mouse)
was injected into the mouse lower gingiva on days 0, 2 and 4. As a control, PBS was
injected into the lower gingiva at each time point. EGCG (0.5 mg/mouse) was
injected into the mouse lower gingiva with or without LPS in some animals. The
mandibular alveolar bone was collected seven days after the ﬁrst injection, and the
BMD of the mandibular alveolar bones was measured. The data are expressed as the
means ± SEM of 11–12 mice. A signiﬁcant difference between the two groups is
indicated by: ⁄⁄p < 0.01 vs. control, #P < 0.05, vs. LPS.3. Results
3.1. EGCG recovers LPS-induced bone resorption in mouse calvarial
organ cultures
Bone resorption is mediated by osteoclasts, and induces the loss
of calciﬁed bone tissue. Organ culture of mouse calvaria is a typical
ex vivo assay system to deﬁne the effects of a test compound on
bone resorption and bone loss, and all bone-resorbing factors are
known to induce bone-resorbing activity in this type of model.
Using ex vivo cultures, we observed that bone-resorbing activity
was induced by adding bone resorbing factors, including LPS.
Catechins are one of the major ﬂavonoids present in plant materi-
als, including tea. EGCG is a major component of green tea cate-
chins (Fig. 1A), and shows the strongest effects among the
known catechins on various cell functions. To examine the effects
of EGCG on inﬂammatory bone resorption, we added EGCG with
or without LPS in the mouse calvarial ex vivo cultures. LPS mark-
edly induced bone-resorbing activity, and EGCG recovered the
bone resorption in a concentration-dependent manner (Fig. 1B).
EGCG did not show any effects on the bone-resorbing activity in
the absence of LPS.
3.2. Effects of EGCG on PGE2 and PGE-related molecules in osteoblasts
We next performed q-PCR to examine the effects of EGCG on
the mRNA expression of PGE-related genes such as COX-1,
COX-2, mPGES-1, mPGES-2, and cPGES, and osteoclast-related
gene RANKL in mouse osteoblasts. LPS markedly induced the
mRNA expression of COX-2, mPGES-1 and mPGES-2 in osteoblasts
after 12–24 h of exposure to LPS, and adding EGCG with the LPS
clearly suppressed the LPS-induced expression of these mRNAs
(Fig. 2A). LPS did not induce the expression of COX-1 or cPGES
mRNA, and EGCG itself also did not inﬂuence the expression of
these genes. EGCG suppressed the LPS-induced expression of
RANKL mRNA in osteoblasts at 12–24 h, indicating that EGCG sup-
presses osteoclastic bone resorption by inhibiting the expression
of RANKL in osteoblasts. In the cultures of osteoblasts, LPS induced
the production of PGE2, and EGCG suppressed this PGE2 produc-
tion induced by LPS (Fig. 2B). Therefore, EGCG acts on osteoblasts
to suppress PGE2 production by negatively regulating COX-2,
mPGES-1 and mPGES-2. The suppressive effects of EGCG on bone
resorption may be elicited by the down-regulation of PGE biosyn-
thesis in osteoblasts.
3.3. Effects of EGCG on LPS-induced bone resorption in mouse
mandibular alveolar bone
Using an organ culture system of mouse mandibular alveolar
bone, we examined the effects of EGCG on bone resorption induced
by LPS. The alveolar bones were collected from mouse lower
mandibles (Fig. 3A), and were cultured with or without LPS. Bone
resorbing activity was measured by the increase in mediumcalcium as shown in the section of Materials and Methods. LPS
markedly induced the bone resorbing activity in organ cultures
of alveolar bone, and adding EGCG clearly suppressed the resorp-
tion of alveolar bone (Fig. 3B). EGCG did not inﬂuence the alveolar
bone resorption in cultures without LPS.
3.4. EGCG inhibits LPS-induced alveolar bone loss in mice
To deﬁne the effects of EGCG on experimental model of bone
loss of alveolar bone, we injected LPS with or without EGCG into
526 T. Tominari et al. / FEBS Open Bio 5 (2015) 522–527the gingiva of the lower mandibles of mice. After seven days of the
ﬁrst injection, alveolar bone was collected from mouse, and the
BMD was measured by DEXA. In this model, LPS markedly
decreased BMD of the mandibular alveolar bone, while the simul-
taneous injection of EGCG signiﬁcantly inhibited the LPS-induced
loss of BMD in mice (Fig. 4). The injection of EGCG without LPS
did not inﬂuence the BMD of the mandibular alveolar bone in mice,
and the BMD was similar to that of control (Fig. 4).
4. Discussion
Green tea is one of the most popular beverages in the world. In
epidemiological studies, the consumption of green tea has been
found to be associated with various beneﬁts, such as a reduced risk
of cancer and cardiovascular disease [8,16]. EGCG is a major com-
ponent of the green tea catechins, and has been reported to show
the strongest effects among the different catechins on various cell
functions, and to exhibit anti-oxidant and anti-tumor activity [8,9].
However, the roles of EGCG in bone tissues are controversial, and
the effects of EGCG on inﬂammatory bone resorption are not
known. In the present study, EGCG suppressed the inﬂammatory
bone resorption induced by LPS in mouse calvarial ex vivo cultures.
We found that EGCG acts on osteoblasts to suppress the
LPS-induced PGE2 production by inhibiting the expression of
COX-2, mPGES-1 and mPGES-2. EGCG also suppressed the expres-
sion of RANKL in osteoblasts. The RANKL expressed on the cell sur-
face of osteoblasts is a key molecule required for osteoclast
differentiation, and the factors that suppress RANKL, such as OPG
and antibodies against RANKL, clearly suppressed osteoclastic bone
resorption. Therefore, EGCG may act on the osteoblasts in bone tis-
sues and suppress the bone resorption associated with inﬂamma-
tion via mechanisms involving both PGE synthesis and RANKL
expression in osteoblasts.
Bone marrow macrophages are known to express RANK, and
osteoclasts are differentiated from the monocyte–macrophage lin-
eage by the RANK-RANKL interaction. In addition to osteoblasts,
macrophages may also be target cells for EGCG. Lin et al. [13]
reported that EGCG acts on RAW264.7 macrophages and inhibits
their differentiation into osteoclasts. We also detected suppressive
effects of EGCG on the soluble RANKL-dependent differentiation of
mouse bone marrow macrophages into osteoclastic cells (data not
shown). Therefore, the action of EGCG on macrophages may par-
tially contribute to the suppressive effects of EGCG on bone
resorption.
It is well known that Toll-like receptors (TLRs) play key roles in
innate immunity, and several TLRs, TLR1-TLR13, were identiﬁed
[17]. The ligands for respective TLR stimulate signal transduction
in the target cells and regulate the host defense system against
pathogens [17]. LPS is an outer membrane component of
Gram-negative bacteria, and acts as a ligand for TLR4 expressed
on cell surface of target cells. We previously reported that mouse
osteoblasts express TLR4 and LPS-TLR4 signaling induces severe
bone resorption associated with inﬂammation [7]. We also
reported that mPGES-1-deﬁcient mice are resistant to both
LPS-induced osteoclast formation and LPS-induced PGE2 produc-
tion in osteoblasts [7]. Therefore, PGE biosynthesis is essential for
the effects of LPS on bone tissues. In the present study, EGCG sup-
pressed the LPS-induced expression of COX-2 and mPGES-1 in
osteoblasts. It may therefore be possible that EGCG interferes with
the signal transduction of TLR4 in osteoblasts. The mechanism of
action of EGCG in LPS-induced and TLR4-mediated PGE biosynthe-
sis in osteoblasts is currently under investigation in our laboratory.
In periodontal diseases, the accumulation of bacterial plaque is
commonly found in the periodontal pocket with the tooth surface
located in the junction between gingiva and tooth. Periodontitis is
a disease associated with bone destruction, and the bacterial LPS isthought to be pathogenic in the periodontal tissues. To examine
the LPS-induced alveolar bone loss in periodontitis, we established
a mouse organ culture system using mouse mandibular alveolar
bone, and an in vivo model of alveolar bone loss by detecting the
BMD of alveolar bone in mice [7,18]. Using the model, we reported
that polymethoxy ﬂavonoids, nobiletin and tangeretin, prevented
LPS-induced inﬂammatory bone loss [19]. In the present study,
we showed that EGCG suppressed the alveolar bone resorption
induced by LPS in vitro, and inhibited the alveolar bone loss
induced by LPS in vivo. Effective dosage of EGCG in vitro and
in vivo shown in Figs. 3 and 4 were similar to those of polymethoxy
ﬂavonoids such as nobiletin [19]. A recent study suggested a possi-
ble role of green tea catechins in preventing periodontal infection
[20,21]. When rats were orally treated with EGCG, the
ligature-induced periodontitis was suppressed by EGCG, measured
by loss of attachment, alveolar bone resorption and inﬂammatory
cytokine expression [20], suggesting systemic administration of
EGCG may have a therapeutic effects of damaged periodontal tis-
sue. Yoshinaga et al. reported that the topical application of green
tea extract with LPS suppressed LPS-induced periodontitis
detected by loss of attachment with alveolar bone and inﬂamma-
tory cell inﬁltration in rats [21], but it is not known which catechin
is effective in the local periodontal tissues. In the present study, we
directly showed the anti-resorption effects of EGCG on mouse
alveolar bone, and suggested that EGCG is effective for preventing
periodontitis by local treatment in periodontal tissues, but further
studies are needed to deﬁne the role of EGCG in the pathogenesis
of human periodontitis. Since EGCG is a major polyphenol in green
tea, one of the most popular beverages consumed worldwide, it
might be useful to perform a human study examining the intake
of green tea on periodontal disease in order to further understand
the possible roles of green tea catechins for the prevention and/or
treatment of periodontitis.
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